New drug aims to keep acid in check for rare kidney disorder
NCT ID NCT03644706
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a medicine called ADV7103 in children and adults with distal renal tubular acidosis (dRTA), a rare kidney condition that causes too much acid in the blood. The goal was to see if ADV7103 could prevent dangerous acid buildup better than a placebo. Only 3 people enrolled before the study was stopped early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DISTAL RENAL TUBULAR ACIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
-
Emory Children's Center
Atlanta, Georgia, 30322, United States
-
J.W. Riley Hospital for Children/Indiana University
Indianapolis, Indiana, 46202, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
-
University of Alberta
Edmonton, Alberta, T6G 2R3, Canada
-
University of South Florida Pediatric Infectious Disease
Tampa, Florida, 33606, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.